NRx Pharmaceuticals Targets Suicidal Bipolar Depression With Multidrug Therapy
NRx's NRX-101 shows promise in clinical trials, aims for FDA approval in 2024 to address unmet medical need.
Zenger ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from Chloe Stevens
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Zenger
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
